After cancer: Study explores caring-healing modalities for survivors
Peer-Reviewed Publication
Updates every hour. Last Updated: 10-Nov-2025 15:11 ET (10-Nov-2025 20:11 GMT/UTC)
Healing doesn’t end with treatment. As cancer survivorship grows, many continue to struggle with anxiety and depression – often in silence. A new review highlights how caring-healing modalities (CHMs) like mindfulness and peer support can build resilience and reduce emotional distress. These human-centered approaches shift focus from treatment to healing, helping survivors reclaim their sense of self. Rooted in empathy and emotional expression, CHMs offer a whole-person approach that meets the deep psychological needs often overlooked in survivorship care –especially among breast cancer survivors.
The Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology in Stuttgart has developed a pioneering therapeutic approach for breast cancer patients who respond poorly to the standard drug tamoxifen. The innovative combination therapy has been successfully tested in a clinical trial under the name TAMENDOX. The results have now been published in the renowned journal Clinical Cancer Research. The project was funded by the German Federal Ministry of Research, Technology, and Space.
The study, published in the journal Oncogene, shows how a specific molecular interaction determines the effectiveness of irinotecan in this type of paediatric cancer
POSTECH-UCLA Collaborative Team Develops Novel ‘Univody’ Platform for Antigen-Independent Cancer Immunotherapy.
July 10, 2025 - A research team led by Professor Yiwei Li and Professor Bi-Feng Liu from the College of Life Science and Technology at Huazhong University of Science and Technology (HUST) published an important research article titled "Mechanical Cell Reprogramming on Tissue-Mimicking Hydrogel for Cancer Cell Transdifferentiation" in the journal Research. The paper can be accessed through this link: https://spj.science.org/doi/10.34133/research.0810.
Professor Yiwei Li and Professor Bi-Feng Liu serve as corresponding authors, with doctoral students Xueqing Ren and Research Scientist Dr. Yachao Wang as co-first authors.
This study developed an innovative tissue-mimicking hydrogel system that achieves cell reprogramming through purely mechanical signals for the first time. The technology not only enhances the stemness and bidirectional differentiation potential of fibroblasts but also promotes cancer cell transdifferentiation into adipocytes, providing novel therapeutic strategies for regenerative medicine and cancer treatment.
UC Irvine researchers have invented an artificial colon to be used in disease anaysis and drug assessment. They envision taking a patient’s own cells from a tumor biopsy and growing a personalized mini-colon to determine which drug works best for that individual patient. Innovation provides cost-effective and ethical approach to disease treatment.
For children and young adults diagnosed with osteosarcoma, a common type of bone cancer for that age group, the odds of survival can be devastatingly low (20-30%) when the disease spreads to the lungs. In an effort to improve the outcomes for these young patients, the Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded a two-year, $198,822 grant to Balakrishna Koneru, Ph.D., from TTUHSC’s School of Medicine and Graduate School of Biomedical Sciences.